Cellectar Biosciences (NV40.F) Q4 2025 Earnings

Nov 13Confirmed
Q2 2025
Q3 2025
Q4 2025
-4.38
-3.32
-2.27
-1.21

Details

Expected EPS
-2.1730317925
Actual EPS
-1.212459
Surprise EPS
0.96
Surprise Percent
+44.2%

Description

⁨Cellectar Biosciences⁩ (⁦NV40.F⁩) has reported earnings of ⁦-1.212459⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts